Want to see HK:0512 full AI Analyst Report?
Total Valuation
Grand Pharmaceutical Group Limited has a market cap or net worth of HK$16.43B. The enterprise value is HK$20.34B.
Market CapHK$16.43B
Enterprise ValueHK$20.34B
Share Statistics
Grand Pharmaceutical Group Limited has 3,549,571,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding3,549,571,000
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Grand Pharmaceutical Group Limited’s return on equity (ROE) is 0.07 and return on invested capital (ROIC) is 3.82%.
Return on Equity (ROE)0.07
Return on Assets (ROA)0.05
Return on Invested Capital (ROIC)3.82%
Return on Capital Employed (ROCE)0.05
Revenue Per Employee973.78K
Profits Per Employee98.37K
Employee Count12,614
Asset Turnover0.45
Inventory Turnover3.71
Valuation Ratios
The current PE Ratio of Grand Pharmaceutical Group Limited is 14.7. Grand Pharmaceutical Group Limited’s PEG ratio is -0.45.
PE Ratio14.7
PS Ratio2.24
PB Ratio1.62
Price to FCF35.50
Price to Operating Cash Flow10.62
PEG Ratio-0.45
Income Statement
In the last 12 months, Grand Pharmaceutical Group Limited had revenue of 12.28B and earned 1.24B in profits. Earnings per share was 0.35.
Revenue12.28B
Gross Profit6.78B
Operating Income1.04B
Pretax Income1.49B
Net Income1.24B
EBITDA2.35B
Earnings Per Share (EPS)0.35
Cash Flow
In the last 12 months, operating cash flow was 1.55B and capital expenditures -712.44M, giving a free cash flow of 838.48M billion.
Operating Cash Flow1.55B
Free Cash Flow838.48M
Free Cash Flow per Share0.24
Dividends & Yields
Grand Pharmaceutical Group Limited pays an annual dividend of HK$0.169, resulting in a dividend yield of 3.59%
Dividend Per ShareHK$0.169
Dividend Yield3.59%
Payout Ratio52.21%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.71
52-Week Price Change-38.84%
50-Day Moving Average5.03
200-Day Moving Average6.02
Relative Strength Index (RSI)37.74
Average Volume (3m)4.15M
Important Dates
Grand Pharmaceutical Group Limited upcoming earnings date is Mar 17, 2027, TBA (Confirmed).
Last Earnings DateAug 26, 2026
Next Earnings DateMar 17, 2027
Ex-Dividend Date―
Financial Position
Grand Pharmaceutical Group Limited as a current ratio of 1.14, with Debt / Equity ratio of 29.27%
Current Ratio1.14
Quick Ratio0.93
Debt to Market Cap0.17
Net Debt to EBITDA1.51
Interest Coverage Ratio6.42
Taxes
In the past 12 months, Grand Pharmaceutical Group Limited has paid 249.78M in taxes.
Income Tax249.78M
Effective Tax Rate0.17
Enterprise Valuation
Grand Pharmaceutical Group Limited EV to EBITDA ratio is 13.22, with an EV/FCF ratio of 40.09.
EV to Sales2.53
EV to EBITDA13.22
EV to Free Cash Flow40.09
EV to Operating Cash Flow20.69
Balance Sheet
Grand Pharmaceutical Group Limited has HK$1.27B in cash and marketable securities with HK$5.05B in debt, giving a net cash position of -HK$3.78B billion.
Cash & Marketable SecuritiesHK$1.27B
Total DebtHK$5.05B
Net Cash-HK$3.78B
Net Cash Per Share-HK$1.07
Tangible Book Value Per ShareHK$3.49
Margins
Gross margin is 52.11%, with operating margin of 8.49%, and net profit margin of 10.10%.
Gross Margin52.11%
Operating Margin8.49%
Pretax Margin12.16%
Net Profit Margin10.10%
EBITDA Margin19.12%
EBIT Margin14.38%
Analyst Forecast
The average price target for Grand Pharmaceutical Group Limited is HK$8.29, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price TargetHK$8.29
Price Target Upside55.83% Upside
Analyst ConsensusModerate Buy
Analyst Count2
Revenue Growth Forecast7.35%
EPS Growth Forecast-45.49%